Drug Detail

Information about Opdivo

Generic Name
Nivolumab
IND
BMS-936558
Brand Name (US)
Opdivo
Manufacturer
Bristol-Myers Squibb
Drug Type
Delivery
Intravenous
Approval Status
Approved for a non-GIST cancer
Indications
Overall Strategy
Immune system
Strategy
Immunotherapy
Drug Category
PD-1 Inhibitor


Links


Trials of this drug


Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed